Chargement en cours...
Advances in autoimmune myasthenia gravis management
INTRODUCTION. Myasthenia gravis (MG) is an autoimmune neuromuscular disorder with no cure and conventional treatments limited by significant adverse effects and variable benefit. In the last decade, therapeutic development has expanded based on improved understanding of autoimmunity and financial in...
Enregistré dans:
| Publié dans: | Expert Rev Neurother |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6289049/ https://ncbi.nlm.nih.gov/pubmed/29932785 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737175.2018.1491310 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|